Facial Palsy

Fig. 1 - The course and intracranial branches of the facial nerve

Figure 1 – The course and intracranial branches of the facial nerve

A facial palsy is weakness or paralysis of the muscles of the face.

Whilst the majority of cases are idiopathic, termed Bell’s Palsy, there are a wide range of potential causes of a facial palsy (see Differential Diagnosis).

Bell’s palsy is a diagnosis of exclusion and hence all possible causes have to be excluded first prior to diagnosing Bell’s palsy. The majority of this article will discuss Bell’s Palsy and its associated clinical features and management.


Risk Factors

Bell’s palsy remains a poorly understood condition. Many causative associations have been proposed, the most universally accepted theory suggests a viral origin, yet no conclusive evidence is available at present.

The main risk factor for developing Bell’s palsy is known concurrent viral infection, such as HSV-1, CMV, and EBV, whilst less common risk factors include diabetes mellitus and pregnancy.

Fig. 2 - The unilateral facial weakness of a facial palsy

Figure 2 – The unilateral facial weakness of a facial palsy


Clinical Features

Patients with a Bell’s Palsy will present with varying severity of painless unilateral lower motor neuron weakness of the facial muscles (Fig. 2).

Depending on the severity and the proximity of the nerve affected, it can also result in:

  • Inability to close their eye (temporal and zygomatic branches)
  • Hyperacusis (nerve to stapedius)
  • Metallic taste (chorda tympani)
  • Reduced lacrimation (greater petrosal nerve)

To distinguish clinically between a LMN cause and UMN cause of the facial palsy, a patient with forehead sparing (i.e. no involvement to the occipitofrontalis muscle) will have a UMN origin to the palsy, due to the bilateral innervation of the forehead muscle).

Severity Grading of a Facial Palsy

The House-Brackmann classifcation can be used to grade facial weakness as it can be used to assess for any clinical changes on follow up and guide prognosis.

Grade Description Characteristics
I Normal Normal facial function in all areas.
II Mild Dysfunction Slight weakness noticeable on close inspection; may have very slight synkinesis.
III Moderate Dysfunction Obvious, but not disfiguring, differences between 2 sides. Noticeable, but not severe, synkinesis or hemifacial spasm. Complete eye closure with effort.
IV Moderately Severe Dysfunction Obvious weakness of disfiguring asymmetry, normal symmetry and tone at rest but unable to complete eye closure.
V Severe Dysfunction Only barely perceptible facial muscle motion, asymmetry at rest.
VI Complete paralysis No movement


Fig. 3 - Involvement of the forehead seen in a case of Bell's Palsy

Fig. 3 – Involvement of the forehead seen in a case of Bell’s Palsy (lower motor neurone palsy)

Differential Diagnosis

Important differential diagnosis for a facial palsy, other than Bell’s Palsy, include:

  • UMN causes, such as a stroke, SDH, or tumour
    • Will present with forehead sparing
  • LMN causes
    • Infective such as acute otitis media, cholesteatoma, viral infection (including HSV-1, CMV, and EBV)
    • Neoplasm (parotid malignancy)
    • Trauma or iatrogenic
    • Neurological (Multiple Sclerosis or Guillain-Barré syndrome)

 

Screen Shot 2016-10-26 at 15.29.36

Figure 4 – The terminal motor branches of the facial nerve


Investigations

Most cases of Bell’s Palsy can be diagnosed clinically and no further investigations are required, unless any other clinical features are present that suggest another pathology.

Serology for HSV-1 and VZV can be performed, yet will unlikely alter future management if detected.


Management

Patient reassurance is essential, as most cases return spontaneously to full function. Eye care is one of the most important aspect of the management, ensuring the patient uses lubricating drops hourly and potential for eye ointment at night and / or an eye patch.

Medical Management

All patients presenting within 72 hours of symptoms onset should be started oral steroids. Current NICE guidance recommends either:

  • Giving 25 mg twice daily for 10 days
  • Giving 60 mg daily for five days followed by a daily reduction in dose of 10 mg

Use of anti-viral agents is controversial. A Cochrane Review found low level evidence that the combination of anti-virals and corticosteroids are more effective in Bell’s palsy treatment; many centers currently treat Bell’s palsy with both.

Surgical Referral

Referral to an ENT surgeon should be considered if there is any doubt over the diagnosis, recurrent or bilateral Bell’s palsy, or no sign of improvement after 1 month.

There are surgical options available for patients who have persistent weakness or synkinesis. Synkinesis could be treated with botox injections whilst persistent weakness can be treated with anterior belly of diagastric transfer, fascia lata sling, or cross-facial nerve grafting.

A referral to ophthalmology should be made if the cornea remains exposed after attempting to close the eyelid (House Brackmann grade of IV or more).


Complications

85% of cases will recover from Bell’s palsy, the majority of which make a fully recovery with no evidence of residual symptoms. The factors that suggest a poor prognosis from a facial palsy include:

  • Complete palsy
  • No signs of recovery within 3 weeks
  • Age >60yrs
  • Associated pain
  • Ramsey Hunt syndrome
  • Associated HTN, DM, or pregnancy

Ramsay-Hunt Syndrome

Fig. 5 - An illustration of the auricular vesicles seen in a case of Ramsay-Hunt syndrome

Figure 5 – An illustration of the auricular vesicles seen in a case of Ramsay-Hunt syndrome

Ramsay Hunt Syndrome is a Herpes Zoster oticus, whereby there is a unilateral facial palsy caused by reactivation of varicella zoster virus from the geniculate nucleus, the nucelus of the facial nerve.

Clinical Features

It typically initially presents with a moderate to severe ear pain with few other overt clinical signs. Within a few days this will develop into a facial palsy, accompanied by ipsilateral vertigo, hyperacusis, and tinnitus.

Vesicles will be visible during this latter period (Fig. 5), covering the concha, anterior ⅔ tongue, and / or the soft palate.

The facial palsy that develop from Ramsey-Hunt syndrome tend to be more severe than a Bell’s Palsy, with only 10% of cases making a complete recovery if left untreated.

Investigation and Management

Diagnosis is clinical; virology studies can be requested if necessary but will add little benefit to the overall diagnosis and management

The treatment involves a combination of prednisolone and acyclovir as early as possible. Unfortunately, only around 75% of cases will resolve with this treatment. Other complications of Ramsey-Hunt syndrome include chronic tinnitus and vestibular dysfunction.

Key Points

  • Facial palsy is weakness or paralysis of the muscles of the face, the most common cause of which is Bell’s Palsy
  • Forehead sparing can be used to distinguish between UMN and LMN causes
  • Most cases of Bell’s palsy resolve spontaneously and management is conservative (steroids +/-anti-virals)
  • Ramsay Hunt Syndrome is a Herpes Zoster oticus and has a worse outcome than Bell’s Palsy

Quiz

Question 1 / 4
Which of the following is not a branch of the facial nerve?

Quiz

Question 2 / 4
Which of the following is not a risk factor for developing Bell's Palsy?

Quiz

Question 3 / 4
What is the current advised management of Bell's Palsy presenting within 72hours of symptom onset?

Quiz

Question 4 / 4
Which virus is implemented in Ramsey Hunt syndrome?

Results

Further Reading

Combined Corticosteroid and Antiviral Treatment for Bell Palsy
de Almeida et al., JAMA

Rate This Article

Average Rating:

Not yet rated